Healthcare · Vaccine antigens production

Vaccine antigens production in Afghanistan in 2026

Afghanistan produces no vaccine antigens — the figure in 2026 stands at 0 million doses. The country relies entirely on international vaccine shipments, including via COVAX and UNICEF. A lack of biopharmaceutical plants and skilled personnel makes domestic production unfeasible. While China produces billions of doses, Afghanistan focuses on storing and distributing finished vaccines amid a weak cold chain. It ranks 72nd out of 197 countries in this indicator.

Data for 2026 · unit: million doses
Position

Afghanistan world ranking

#72 / 197

Country position on the scale from last to first place for this indicator.

AF
#72
#197#1
Trend

Change over time

Change in indicator over the available period.

0
1950
0
1990
0
2000
0
2010
0
2020
0
2025
0
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Afghanistan — how much?
Based on 2026 data — 0 million doses. This is rank #72 out of 197 countries.
What is Afghanistan's rank by Vaccine antigens production?
Afghanistan ranks #72 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Afghanistan?
Over the available period the indicator changed from 0 to 0 million doses.